Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Corvus Pharmaceuticals Inc (NASDAQ:CRVS) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 9.59M a 9.67M. Questo rappresenta il 16.42% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Corvus Pharma Corp (XNAS:CRVS) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 628.98K azioni scambiate al giorno, ci vorrebbero 15.37 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
9.67M
Vendite allo scoperto %
16.4%
Giorni di copertura
15.37
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CRVS | Corvus Pharmaceuticals, Inc. C | 09/15/2025 | 09/24/2025 | 16.42% | 58,892,804 | 9,670,508 | 628,977 | 15.37 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 08/29/2025 | 09/10/2025 | 16.29% | 58,892,804 | 9,593,924 | 545,025 | 17.6 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 08/15/2025 | 08/26/2025 | 15.78% | 58,892,804 | 9,294,023 | 494,223 | 18.81 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 07/31/2025 | 08/11/2025 | 14.30% | 61,493,401 | 8,792,759 | 444,258 | 19.79 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 07/15/2025 | 07/24/2025 | 14.61% | 61,493,401 | 8,984,611 | 566,620 | 15.86 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 06/30/2025 | 07/10/2025 | 14.48% | 61,493,401 | 8,904,387 | 1,531,874 | 5.81 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 06/13/2025 | 06/25/2025 | 12.91% | 61,493,401 | 7,939,714 | 899,988 | 8.82 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 05/30/2025 | 06/10/2025 | 11.51% | 61,493,401 | 7,080,956 | 658,871 | 10.75 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 05/15/2025 | 05/27/2025 | 11.76% | 61,493,401 | 7,231,927 | 2,016,541 | 3.59 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 04/30/2025 | 05/09/2025 | 10.99% | 52,548,226 | 5,774,289 | 968,288 | 5.96 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 04/15/2025 | 04/25/2025 | 9.54% | 56,000,190 | 5,340,977 | 825,776 | 6.47 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 03/31/2025 | 04/09/2025 | 8.78% | 56,000,190 | 4,916,177 | 802,393 | 6.13 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 03/14/2025 | 03/25/2025 | 10.34% | 52,121,645 | 5,391,839 | 568,293 | 9.49 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 02/28/2025 | 03/11/2025 | 10.26% | 52,121,645 | 5,348,002 | 735,089 | 7.28 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 02/14/2025 | 02/26/2025 | 11.00% | 52,121,645 | 5,732,606 | 376,784 | 15.21 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 01/31/2025 | 02/11/2025 | 11.72% | 52,121,645 | 6,108,482 | 442,699 | 13.8 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 01/15/2025 | 01/27/2025 | 10.56% | 52,121,645 | 5,501,782 | 649,002 | 8.48 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 12/31/2024 | 01/10/2025 | 10.42% | 52,121,645 | 5,429,471 | 2,441,320 | 2.22 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 12/13/2024 | 12/24/2024 | 8.26% | 52,121,645 | 4,305,523 | 796,874 | 5.4 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 11/29/2024 | 12/10/2024 | 6.74% | 52,121,645 | 3,514,354 | 640,162 | 5.49 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 11/15/2024 | 11/26/2024 | 6.33% | 52,121,645 | 3,300,809 | 1,138,921 | 2.9 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 10/31/2024 | 11/11/2024 | 5.80% | 50,415,675 | 2,925,030 | 1,055,217 | 2.77 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 10/15/2024 | 10/24/2024 | 4.85% | 50,415,675 | 2,444,921 | 488,043 | 5.01 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 09/30/2024 | 10/09/2024 | 4.26% | 50,415,675 | 2,149,980 | 530,601 | 4.05 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 09/13/2024 | 09/24/2024 | 3.25% | 50,415,675 | 1,639,326 | 457,501 | 3.58 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 08/30/2024 | 09/11/2024 | 2.84% | 50,415,675 | 1,434,294 | 366,624 | 3.91 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 08/15/2024 | 08/26/2024 | 2.71% | 50,415,675 | 1,366,297 | 535,763 | 2.55 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 07/31/2024 | 08/09/2024 | 2.28% | 50,415,675 | 1,147,839 | 190,117 | 6.04 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 07/15/2024 | 07/24/2024 | 2.49% | 50,415,675 | 1,254,494 | 118,969 | 10.54 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 06/28/2024 | 07/10/2024 | 2.84% | 50,415,675 | 1,430,669 | 218,997 | 6.53 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 06/14/2024 | 06/26/2024 | 2.98% | 50,415,675 | 1,504,810 | 136,281 | 11.04 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 05/31/2024 | 06/11/2024 | 3.01% | 50,415,675 | 1,518,863 | 185,437 | 8.19 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 05/15/2024 | 05/24/2024 | 2.55% | 50,415,675 | 1,286,773 | 515,162 | 2.5 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 04/30/2024 | 05/09/2024 | 2.69% | 50,415,675 | 1,356,353 | 102,771 | 13.2 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 04/15/2024 | 04/24/2024 | 3.70% | 36,902,976 | 1,365,312 | 181,575 | 7.52 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 03/28/2024 | 04/09/2024 | 3.79% | 36,912,976 | 1,397,624 | 252,928 | 5.53 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 03/15/2024 | 03/26/2024 | 4.05% | 36,912,976 | 1,493,650 | 223,547 | 6.68 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 02/29/2024 | 03/11/2024 | 3.45% | 36,912,976 | 1,272,864 | 192,521 | 6.61 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 02/15/2024 | 02/27/2024 | 3.45% | 36,912,976 | 1,273,651 | 247,052 | 5.16 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 01/31/2024 | 02/09/2024 | 3.73% | 36,912,976 | 1,378,106 | 123,892 | 11.12 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 01/12/2024 | 01/24/2024 | 3.79% | 36,912,976 | 1,398,986 | 283,149 | 4.94 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 12/29/2023 | 01/10/2024 | 3.61% | 36,912,976 | 1,331,893 | 190,490 | 6.99 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 12/15/2023 | 12/27/2023 | 3.53% | 36,912,976 | 1,303,196 | 264,267 | 4.93 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 11/30/2023 | 12/11/2023 | 4.26% | 36,912,976 | 1,571,657 | 129,121 | 12.17 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 11/15/2023 | 11/27/2023 | 4.85% | 36,912,976 | 1,792,120 | 372,417 | 4.81 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 10/31/2023 | 11/09/2023 | 4.64% | 36,912,976 | 1,713,418 | 143,849 | 11.91 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 10/13/2023 | 10/24/2023 | 4.81% | 36,840,256 | 1,771,929 | 107,079 | 16.55 | |
CRVS | Corvus Pharmaceuticals, Inc. C | 09/29/2023 | 10/10/2023 | 4.81% | 36,840,256 | 1,771,810 | 176,887 | 10.02 |
In cerca di azioni più vendute allo scoperto?